-

SHAREHOLDER ALERT: Robbins LLP Announces That Canaan Inc. (CAN) is Being Sued for Misleading Shareholders

SAN DIEGO & HANGZHOU, China--(BUSINESS WIRE)--Shareholder rights law firm Robbins LLP announces that a purchaser of Canaan Inc. (NASDAQ: CAN) filed a class action complaint against the Company and its officers and directors for alleged violations of the Securities Exchange Act of 1934 between February 10, 2021 and April 9, 2021. Canaan designs, manufactures and sells bitcoin mining machines, primarily in the People's Republic of China.

If you suffered a loss due to Canaan Inc.'s misconduct, click here.

Canaan Inc. (CAN) Made Misstatements Regarding its Business Metrics and Financial Prospects

According to the complaint, on February 10, 2021, Canaan issued a press release announcing that its "revenue visibility ha[d] improved substantially" and making other positive statements about purported visibility into increases in the size and quality of the orders it had been receiving. In response to these statements, Canaan's ADR price increased nearly 90% between its opening on Monday, February 8th and closing on February 12th.

Contrary to these statements, Canaan's significant ongoing supply chain disruptions and the introduction of the Company's next-generation A12 series bitcoin mining machines, had actually caused the Company's 4Q20 sales to decline more than 93% year-over-year compared to its third quarter 3Q20 sales. As a result, Canaan's 4Q20 total net revenues had decreased to RMB38.2 million (US$5.9 million) from RMB463.2 million in the 4Q19 and RMB163.0 million in the 3Q20.

On April 12, 2021, Canaan issued a press release disclosing its actual 4Q20 and FY20 financial results for the period ended December 31, 2020, including a 93% year-over-year decrease in computing power sold and net revenues for the quarter. On this news, Canaan ADRs collapsed nearly 30%.

If you purchased shares of Canaan Inc. (CAN) between February 10, 2021 and April 9, you have until June 14, 2021, to ask the court to appoint you lead plaintiff for the class.

All representation is on a contingency fee basis. Shareholders pay no fees or expenses.

Contact us to learn more:
Lauren Levi
(800) 350-6003
llevi@robbinsllp.com
Shareholder Information Form

Robbins LLP is a nationally recognized leader in shareholder rights law. To be notified if a class action against Canaan Inc. settles or to receive free alerts about companies engaged in wrongdoing, sign up for Stock Watch today.

Attorney Advertising. Past results do not guarantee a similar outcome.

Contacts

Contact:
Lauren Levi
Robbins LLP
5040 Shoreham Place
San Diego, CA 92122
llevi@robbinsllp.com
(800) 350-6003
www.robbinsllp.com

More News From Robbins LLP

Investor Notice: Robbins LLP Informs Investors of the Medpace Holdings Inc. Class Action

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP informs stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Medpace Holdings Inc. (NASDAQ: MEDP) securities between April 22, 2025 and February 9, 2026. Medpace is a clinical contract research organization (CRO) focused on providing scientifically driven outsourced clinical development services to the biotechnology, pharmaceutical, and medical device industries. For more information, submit a form, ema...

Snowflake Inc. Class Action Reminder - Robbins LLP Encourages SNOW Stockholders to Contact the Firm for Information About Their Rights

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP reminds stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Snowflake Inc. (NYSE: SNOW) Class A common stock between June 27, 2023 and February 28, 2024. Snowflake is a software company that provides cloud data storage that enables customers to consolidate data onto data-driven applications and share data for the purpose of running analytics and other processes. For more information, submit a form, ema...

Corcept Therapeutics Incorporated Class Action Reminder – Robbins LLP Encourages CORT Stockholders to Contact the Firm for Information About Their Rights

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP reminds stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Corcept Therapeutics Incorporated (NASDAQ: CORT) common stock between October 31, 2024 and December 30, 2025. Corcept is a pharmaceutical company focused on the development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol.For more information, submit a...
Back to Newsroom